[Online Seminar held on March 3th] Re-streamed due to popular demand! The next global trend is anti-aging. New common sense for anti-aging and health led by AI drug discovery support
In this seminar, the developer of KIBIT Amanogawa, a research paper exploration AI that can discover the unknown from the known, will introduce new anti-aging possibilities revealed by AI analysis. In particular, he will focus on Klotho, a substance known to be closely related to anti-aging, and s-Klotho, which leaks into the blood and circulates throughout the body. He will explain through examples of research paper x AI analysis how mugwort as a food and exercise can activate this substance and contribute to the prevention and treatment of aging-related heart disease, diabetes, Alzheimer's disease, and other conditions.
*Please note that this seminar will be a recording of the seminar held on February 2th (Wednesday), excluding the opening and Q&A sessions.
[Date and time] Thursday, November 2025, 3 27:11~30:12
Format: Online (Zoom Webinars)
[Participation conditions]
We may decline applications from people using free email addresses, people in the same industry as us, and people whose affiliation is unknown. When accessing Zoom on the day, please enter the name and email address you provided when applying in the Zoom participation input field.
◎Lecturer

FRONTEO Inc.
Director/CTO PhD (Science)
Hiroyoshi Toyoshiba
Ph.D. in Mathematics. Since 2000, he has participated in research on the carcinogenesis process through data analysis at the National Institute of Environmental Health Sciences (NIEHS). In 2006, he joined Takeda Pharmaceutical Company, where he served as a researcher in the bioinformatics field, head of bioinformatics at the Global Data Science Institute Japan site, and science fellow. In 2017, he joined FRONTEO to develop AI algorithms specialized in the field of life sciences. To date, various AI solutions based on these algorithms have been commercialized, including paper search, drug discovery support, dementia diagnosis support, and fall prediction. He has been appointed CTO of Life Science AI since 2019, and a director since 2024.
◎ Moderator and Q&A
FRONTEO Inc.
Life Science AI Business Headquarters
AI drug discovery team manager
Go Nakazono
Majored in applied physics at Fukuoka University Faculty of Science.
Worked as a key account manager in BtoB business in the advertising industry.
In the pharmaceutical industry, he has experience in MR, marketing, academics, etc., mainly targeting rare diseases, blood diseases, and pediatric diseases. His previous job was as an area manager at Takeda Pharmaceutical Company.
Currently working on expanding the AI drug discovery business at the Life Science AI Business Headquarters.
Articles in the same category

[Hybrid Seminar held on June 6th] Discovery-based paper search AI explores the potential of cancer immunotherapy and exosomes as a biomarker

[Online Seminar Held on May 5th] Learn from Case Studies! Real Troubles in M&A: Five Lessons Legal Departments Should Learn

[Online seminar held on May 5] "Prevention" and "Response in the event of an emergency" regarding the taking of trade secrets by former employees <22rd of XNUMX-part course> Prevention - Confidentiality management and leak prevention -

[Online Seminar held on May 5th] Towards an era of fighting at zero cost: Strategic use of TPF

[Hybrid Seminar held on May 5th] Considering the relationship between menopausal symptoms and lipid profile using paper search AI

[Online Seminar held on April 4] Drug Discovery AI Factory × PLOM-CON analysis accelerates novel target discovery and mechanism elucidation

[Online seminar held on April 4th] "Preventive measures" and "emergency response" for cases of former employees taking trade secrets <24nd of XNUMX-part course> Emergency response Emergency response - Civil measures and internal disciplinary measures -

[Online Seminar Held on April 4th] Former JFTC Investigator on the Current State of the Leniency Program - The Role of Digital Forensics and Effective Practical Solutions

[Hybrid Seminar held on April 4th] The theme is hyperhidrosis! Target search and work style reform in your spare time with KIBIT Amanogawa